Generation of polyclonal rabbit antisera to mouse melanoma associated antigens using gene gun immunization

Journal of Immunological Methods

Volumn 214, Issue 1-2, 1998, Pages 51-62

  Surman, Deborah R ^a   Irvine, Kari R ^a   Shulman, Eliza P ^a   Allweis, Tanir M ^a   Rosenberg, Steven A ^a   Restifo, Nicholas P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gene gun immunization; Melanoma antigen; Polyclonal antisera; Recombinant anti cancer vaccines

Indexed keywords

CANCER VACCINE; MELANOMA ANTIGEN; POLYCLONAL ANTIBODY; RECOMBINANT VACCINE;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BIOLISTIC TRANSFORMATION; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; GENE TARGETING; IMMUNIZATION; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELLS, CULTURED; DNA, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; HAPLORHINI; HUMANS; IMMUNE SERA; IMMUNIZATION, PASSIVE; KIDNEY; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM PROTEINS; PLASMIDS; RABBITS; VACCINIA VIRUS;

ANIMALIA; MURINAE; ORYCTOLAGUS CUNICULUS; VACCINIA; VACCINIA VIRUS;

EID: 0031840486     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00036-2     Document Type: Article

References (30)

1. Attanasio R., Pehler K., Scinicariello F. DNA-based immunization induces anti-CD4 antibodies directed primarily to native epitopes. FEMS Immunol. Med. Microbiol. 17:1997;207.
2. Barry M.A., Barry M.E., Johnston S.A. Production of monoclonal antibodies by genetic immunization. Biotechniques. 16:1994;616.
3. Bouchard B., Fuller B.B., Vijayasaradhi S., Houghton A.N. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J. Exp. Med. 169:1989;2029.
4. Chapman B.S., Thayer R.M., Vincent K.A., Haigwood N.L. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic. Acids Res. 19:1991;3979.
5. Chen Y.T., Stockert E., Jungbluth A., Tsang S., Coplan K.A., Scanlan M.J., Old L.J. Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5915.
6. Chen Y.T., Stockert E., Tsang S., Coplan K.A., Old L.J. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8125.
7. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278.
8. Fuller D.H., Haynes J.R. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retroviruses. 10:1994;1433.
9. Gown A.M., Vogel A.M., Hoak D., Gough F., McNutt M.A. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am. J. Pathol. 123:1986;195.
10. Haynes J.R., McCabe D.E., Swain W.F., Widera G., Fuller J.T. Particle-mediated nucleic acid immunization. J. Biotechnol. 44:1996;37.
11. Irvine K.R., Rao J.B., Rosenberg S.A., Restifo N.P. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156:1996;238.
12. Jiminez M., Tsukamoto K., Hearing V.J. Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J. Biol. Chem. 266:1991;1147.
13. Kameyama K., Takemura T., Hamada Y., Sakai C., Kondoh S., Nishiyama S., Urabe K., Hearing V.J. Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP-1), DOPAchrome tautomerase (TRP-2), and a melanogenic inhibitor. J. Invest. Dermatol. 100:1993;126.
14. Kawakami Y., Battles J.K., Kobayashi T., Ennis W., Wang X., Tupesis J.P., Marincola F.M., Robbins P.F., Hearing V.J., Gonda M.A., Rosenberg S.A. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1. J. Immunol. Meth. 202:1997;13.
15. Kobayashi T., Urabe K., Orlow S.J., Higashi K., Imokawa G., Kwon B.S., Potterf B., Hearing V.J. The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function. J. Biol. Chem. 269:1994;2919.
16. Krasemann S., Groschup M., Hunsmann G., Bodemer W. Induction of antibodies against human prion proteins (PrP) by DNA-mediated immunization of PrP0/0 mice. J. Immunol. Meth. 199:1996;109.
17. Overwijk, W., Tsung, A., Irvine, K.R., Parkhurst, M.R., Goletz, T.J., Tsung, K., Carroll, M.W., Liu, C., Moss, B., Rosenberg, S.A., Restifo, N.P., 1998. gp100/pmel 17 is a murine tumor rejection antigen: Induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J. Exp. Med. in press.
18. Pan Z.K., Ikonomidis G., Lazenby A., Pardoll D., Paterson Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat. Med. 1:1995;471.
19. Pertmer T.M., Eisenbraun M.D., McCabe D., Prayaga S.K., Fuller D.H., Haynes J.R. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine. 13:1995;1427.
20. Robbins P.F., Kawakami Y. Human tumor antigens recognized by T cells. Curr. Opin. Immunol. 8:1996;628.
21. Rosenberg S.A. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today. 18:1997;175.
22. Rosenberg S.A., White D.E. Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy. J. Immunother. Emphasis. Tumor Immunol. 19:1996;81.
23. Sakai C., Kawakami Y., Law L.W., Furumura M., Hearing V.J.J. Melanosomal proteins as melanoma-specific immune targets. Melanoma Res. 7:1997;83.
24. Shibahara S., Tomita Y., Sakakura T., Nager C., Chaudhuri B., Muller R. Cloning and expression of cDNA encoding mouse tyrosinase. Nucleic Acids Res. 14:1986;2413.
25. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152.
26. Thomson T.M., Mattes M.J., Roux L., Old L.J., Lloyd K.O. Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody. J. Invest. Dermatol. 85:1985;169.
27. Vennegoor C., Hageman P., Van N.H., Ruiter D.J., Calafat J., Ringens P.J., Rumke P. A monoclonal antibody specific for cells of the melanocyte lineage. Am. J. Pathol. 130:1988;179.
28. Wang M., Bronte V., Chen P.W., Gritz L., Panicali D., Rosenberg S.A., Restifo N.P. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol. 154:1995;4685.
29. Yamamoto H., Takeuchi S., Kudo T., Makino K., Nakata A., Shinoda T., Takeuchi T. Cloning and sequencing of mouse tyrosinase cDNA. Jpn. J. Genet. 62:1987;271.
30. Zhai Y., Yang J.C., Spiess P., Nishimura M.I., Overwijk W.W., Roberts B., Restifo N.P., Rosenberg S.A. Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART-1 and gp100. J. Immunother. 20:1997;15.